Simponi (golimumab) - Merck (MSD), Mitsubishi Tanabe, J&J
Simponi: Regulatory submissions in US/EU for pediatric ulcerative colitis between 2019-2023 (J&J) - May 16, 2019 - Pharmaceutical Business Review 
European regulatory • sBLA
https://edge.media-server.com/m6/p/jjsewqjm
 
May 16, 2019
 
 
ba76cef2-cdc9-4dba-a130-38b37df2a8a8.jpg